Literature DB >> 21537897

Prevention of stroke following transient ischemic attack.

Sharon Poisson1, S Claiborne Johnston.   

Abstract

Transient ischemic attacks (TIAs) are common neurologic events characterized by stroke-like symptoms that completely resolve. They were previously thought to be benign but research over the past decade has revealed the high risk of further neurologic and cardiac events following TIA. With the knowledge of prognosis following TIA, the need for more urgent diagnostic workup and treatment has become clear, and several tools for identifying patients at the highest risk have been developed. In this review, we discuss appropriate diagnostic testing, acute management, and long-term management for preventing stroke after TIA, current research in progress, as well as areas of need for future research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537897     DOI: 10.1007/s11883-011-0181-4

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  54 in total

1.  Blood pressure and stroke: an overview of published reviews.

Authors:  Carlene M M Lawes; Derrick A Bennett; Valery L Feigin; Anthony Rodgers
Journal:  Stroke       Date:  2004-04       Impact factor: 7.914

2.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

3.  Carotid endarterectomy in the acute phase of crescendo cerebral transient ischemic attacks is safe and effective.

Authors:  Guy Leseche; Jean-Marc Alsac; Yves Castier; Francis Fady; Philippa C Lavallee; Mikael Mazighi; Pierre Amarenco
Journal:  J Vasc Surg       Date:  2010-12-03       Impact factor: 4.268

4.  The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial.

Authors:  E Feldmann; J L Wilterdink; A Kosinski; M Lynn; M I Chimowitz; J Sarafin; H H Smith; F Nichols; J Rogg; H J Cloft; L Wechsler; J Saver; S R Levine; C Tegeler; R Adams; M Sloan
Journal:  Neurology       Date:  2007-04-04       Impact factor: 9.910

5.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

Review 6.  Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis.

Authors:  Matthew F Giles; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2007-11-13       Impact factor: 44.182

7.  Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke.

Authors:  A H Tayal; M Tian; K M Kelly; S C Jones; D G Wright; D Singh; J Jarouse; J Brillman; S Murali; R Gupta
Journal:  Neurology       Date:  2008-09-24       Impact factor: 9.910

8.  Delayed detection of atrial fibrillation after ischemic stroke.

Authors:  Hooman Kamel; Kennedy R Lees; Patrick D Lyden; Philip A Teal; Ashfaq Shuaib; Myzoon Ali; S Claiborne Johnston
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 Nov-Dec       Impact factor: 2.136

9.  Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Daniel E Singer; Gregory W Albers; James E Dalen; Margaret C Fang; Alan S Go; Jonathan L Halperin; Gregory Y H Lip; Warren J Manning
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

10.  Transoesophageal echocardiography in selecting patients for anticoagulation after ischaemic stroke or transient ischaemic attack.

Authors:  M Strandberg; R J Marttila; H Helenius; J Hartiala
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-07       Impact factor: 10.154

View more
  1 in total

Review 1.  Antithrombotic management for transient ischemic attack and ischemic stroke (other than atrial fibrillation).

Authors:  J Donald Easton
Journal:  Curr Atheroscler Rep       Date:  2011-08       Impact factor: 5.113

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.